Elligint Health, Inc. — Form D/A
Elligint Health, Inc. of EDISON, NJ, a company, filed a Form D amendment with the SEC on 2025-06-27. $13.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-06-27
- Form: D/A
- Accession: 0002051403-25-000003
- Industry: Other Technology
- Exemptions: 06b
- Amount sold: $13.1M
- Investors: 56
- Date of first sale: 2024-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-534675
Issuer
- Name: Elligint Health, Inc.
- CIK: 0002051403
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 343 THORNALL STREET, EDISON, NJ, 08837
- Phone: 443-995-2924
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Danielle Bellanger | Director | Edison, NJ |
| Chris Caramanico | Director | Edison, NJ |
| Ashish Kapoor | Director | Toronto, A6 |
| Michael Ludwig | Director | Edison, NJ |
| Lenard Marcus | Director | Hoboken, NJ |
| Gregg Michaelson | Director | New York, NY |
| Enrico Picozza | Director | Edison, NJ |
| Adam Sabloff | Director | Edison, NJ |
| Steven Tolle | Director | Edison, NJ |
| Chris Caramanico | Executive Officer | Edison, NJ |
| Sumesh P Poyil | Executive Officer | Edison, NJ |
Other filings by this issuer (2)
More